Kiniksa Pharmaceuticals International, plc (KNSA)

Import this data to Google Sheets with:

=jivedata("KNSA","financials")

Full statements spill as a table. For one cell: =jivedata("KNSA","Revenue") or =jivedata("KNSA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Kiniksa Pharmaceuticals International, plc

KNSA • CIK 0001730430

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$734	$662	$1,943	$1,986
Operating Lease, Right-of-Use Asset	$11,931	$10,376	$9,807	$9,334
Other Assets, Noncurrent	$827	$10,315	$11,307	$11,162
Finite-Lived Intangible Assets, Net	$17,250	$16,250	$15,250	$15,000
Deferred Income Tax Assets, Net	$219,283	$211,151	$198,149	$193,626
Assets	$526,322	$580,553	$763,633	$825,280
Liabilities	$87,483	$142,117	$196,027	$219,593
Cash and Cash Equivalents, at Carrying Value	$107,954	$183,581	$165,596	$189,952
Short-term Investments	$98,417	$60,046	$248,478	$278,141
Accounts Receivable, after Allowance for Credit Loss, Current	$21,266	$41,724	$15,594	$23,224
Inventory, Net	$31,122	$26,364	$54,895	$73,141
Prepaid Expense and Other Assets, Current	$17,538	$20,084	$42,614	$29,714
Assets, Current	$276,297	$331,799	$527,177	$594,172
Accounts Payable, Current	$8,246	$2,039	$2,028	$24,402
Accrued Liabilities, Current	$44,667	$32,355	$42,020	$32,771
Operating Lease, Liability, Current	$2,253	$1,993	$2,987	$3,170
Other Liabilities, Current	$8,193	$16,077	$22,134	$20,691
Liabilities, Current	$63,666	$100,621	$139,184	$156,611
Contract with Customer, Liability, Noncurrent	$11,954	$31,811	$31,811	$31,811
Operating Lease, Liability, Noncurrent	$10,005	$7,862	$6,510	$5,855
Other Liabilities, Noncurrent	$1,858	$1,823	$18,522	$25,316
Additional Paid in Capital	$916,763	$959,722	$1,029,748	$1,045,877
Accumulated Other Comprehensive Income (Loss), Net of Tax	$6	$-163	$-25	$-665
Retained Earnings (Accumulated Deficit)	$-477,950	$-521,143	$-462,138	$-439,546
Stockholders' Equity Attributable to Parent	$438,839	$438,436	$567,606	$605,687

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$14,084	$-43,193	$59,005	$73,058
Net Cash Provided by (Used in) Operating Activities	$13,301	$25,689	$137,985	$165,860
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$-14,761	$75,627	$-17,985	$32,820
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$107,954	$183,581	$165,596	$198,416
Depreciation, Depletion and Amortization, Nonproduction	$2,341	$1,695	$1,554	$1,677
Proceeds from Sale of Property, Plant, and Equipment	$91	$25	$25	$25
Share-based Payment Arrangement, Noncash Expense	$27,149	$30,693	$37,003	$39,311
Payments to Acquire Property, Plant, and Equipment	$130	$277	$1,568	$1,630
Payments to Acquire Short-term Investments	$204,933	$202,014	$386,915	$468,856
Accretion (Amortization) of Discounts and Premiums, Investments	$1,068	$-441	$916	$-131
Proceeds from Maturities, Prepayments and Calls of Short-term Investments	$175,506	$239,938	$199,490	$301,118
Gain (Loss) on Disposition of Property Plant Equipment	$-179	$-1	$120	$184
Net Cash Provided by (Used in) Investing Activities	$-29,557	$37,672	$-188,993	$-169,368
Deferred Income Tax Expense (Benefit)	$-33,788	$8,132	$13,002	$14,532
Increase (Decrease) in Prepaid Expense and Other Assets	$7,067	$2,710	$22,481	$4,105
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$3,701	$17,250	$40,753	$43,962
Increase (Decrease) in Accounts Receivable	$8,606	$20,458	$-26,130	$-16,841
Payment, Tax Withholding, Share-based Payment Arrangement	$2,206	$4,984	$7,730	$7,634
Increase (Decrease) in Inventories	$9,523	$-4,758	$28,531	$51,072
Net Cash Provided by (Used in) Financing Activities	$1,495	$12,266	$33,023	$36,328
Increase (Decrease) in Contract with Customer, Asset	$-7,656	$-7,656	$-7,656	$-7,656
Increase (Decrease) in Other Noncurrent Assets	$-4,584	$9,735	$1,210	$3,130
Increase (Decrease) in Accounts Payable	$347	$-6,306	$142	$22,346
Increase (Decrease) in Accrued Liabilities	$16,940	$43,729	$37,497	$36,046
Increase (Decrease) in Deferred Revenue	$261	$19,550	$19,550	$19,550
Increase (Decrease) in Other Noncurrent Liabilities	$19	$-35	$16,699	$20,180
Income Taxes Paid, Net	$5,605	$2,003	$3,012	$3,012
Capital Expenditures Incurred but Not yet Paid	$54	$153	$83	$157

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("KNSA","financials")

Full statements spill as a table. For one cell: =jivedata("KNSA","Revenue") or =jivedata("KNSA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.